26.5 C
New York
Friday, June 5, 2026

Tag: quarterly report

Workhorse Group Reports Second Quarter 2025 Results

CINCINNATI, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Workhorse Group Inc. (Nasdaq: WKHS) (“Workhorse” or “the Company”), an American technology company focused on pioneering the transition to zero-emission commercial vehicles, today reported financial results for the second quarter ended June 30, 2025.

Opendoor Announces CEO Search in Support of Next Phase of Growth and Innovation

Shrisha Radhakrishna appointed as President and interim leader of Opendoor
Shrisha Radhakrishna appointed as President and interim leader of Opendoor

BioAge Labs Announces First Participant Dosed in Phase 1 Clinical Trial of BGE-102, a Novel Brain-Penetrant NLRP3 Inhibitor

First-in-human study evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of BGE-102, an orally available small molecule with potential best-in-class profile

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif., Aug. 15, 2025 (GLOBE NEWSWIRE) --  Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options to purchase an aggregate of 42,300 shares of the Company’s stock (the “Inducement Grant”) to newly hired employees on August 12, 2025 (the “Grant Date”), in connection with the commencement of employment.

T1 Energy Announces Rescheduled Earnings Release and Conference Call

AUSTIN, Texas and NEW YORK, Aug. 15, 2025 (GLOBE NEWSWIRE) -- T1 Energy Inc. (NYSE: TE) (“T1,” “T1 Energy,” or the “Company”) announced this morning that the Company has rescheduled its second quarter earnings release and conference call to August 20, 2025. T1’s decision to reschedule the earnings release is to accommodate the Company’s decision to delay the filing of its Quarterly Report on Form 10-Q as permitted under SEC Rules. The Company filed a Form 12b-25 notifying the U.S. Securities and Exchange Commission earlier today.

T1 Energy and Corning Deal Accelerates ‘Made in America’ Solar Momentum

T1 Energy and Corning Deal Boosts U.S. solar supply chain, advances towards domestic solar modules.

VERSES Announces Filing of Quarterly Report on Form 10-Q

VANCOUVER, British Columbia, Aug. 14, 2025 (GLOBE NEWSWIRE) -- VERSES AI Inc. (CBOE: VERS) (OTCQB: VRSSF) ("VERSES" or the "Company"), a cognitive computing company pioneering next-generation agentic software systems today announced that it has filed its Quarterly Report on Form 10-Q (“Quarterly Report”) for the three months ended June 30, 2025, with the U.S. Securities and Exchange Commission (“SEC”).

Akero Therapeutics Announces Lancet Publication of the Phase 2b HARMONY Clinical Trial Demonstrating 96 Weeks Treatment with EFX Reduced Liver Fibrosis in Patients with...

Results support potential of efruxifermin (EFX) to reduce risk of fibrosis progression in patients with pre-cirrhotic (F2-F3) MASH
Results support potential of efruxifermin (EFX) to reduce risk of fibrosis progression in patients with pre-cirrhotic (F2-F3) MASH

SolarMax Technology Reports Second Quarter 2025 Financial Results

RIVERSIDE, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- SolarMax Technology, Inc. (Nasdaq SMXT) (“SolarMax” or the “Company”), an integrated solar energy company, today reported financial results for the quarter ended June 30, 2025.

SUNation Energy Reschedules 2025 Second Quarter Financial Results and Conference Call

SUNation has re-scheduled the release of its second quarter 2025 financial results and conference call.

Emmaus Life Sciences Reports Quarterly Financial Results

TORRANCE, Calif., Aug. 14, 2025 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQB: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell...

VivoSim Labs Appoints Tony Lialin as Chief Commercial Officer

Veteran commercial leader to scale AI-enabled NAMkind™ liver and intestine toxicology services in a rapidly growing market
Veteran commercial leader to scale AI-enabled NAMkind™ liver and intestine toxicology services in a rapidly growing market

GlobalTech Corporation Announces Second Quarter 2025 Results

RENO, Nev., Aug. 14, 2025 (GLOBE NEWSWIRE) -- GlobalTech Corporation (OTCID:GTLK) (“GlobalTech” or the “Company”), a technology holding company specializing in artificial intelligence (AI) and big data solutions, today announced its financial results for the second quarter ended June 30, 2025.

Edible Garden Delivers Strong Performance Across Core and Key Segments, Driven by Strategic Portfolio Transformation

 Company exits low-margin product lines, invests in higher-margin, innovative CEA-informed, better-for-you shelf-stable products, and expands global reach

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsQuarterly report